Mahin Hashemipour - Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Daniel Zamanfar - Diabetes Research Center, Department of Pediatric Endocrinology, Mazandaran University of Medical Sciences, Sari, Iran.
Houman Hashemian - Pediatric Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran.
Afagh Hassanzadeh Rad - Pediatric Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran.
Maryam Shahrokhi - Department of clinical pharmacy, Faculty of Pharmacy, Guilan University of Medical Sciences, Rasht, Iran.
Setila Dalili - Pediatric Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran.

Background: COVID-۱۹ is an unknown and novel virus that creates a challenge with all comorbid conditions, including diabetes mellitus (DM). Although DM has not been determined as a definite risk factor for COVID-۱۹ in childhood, clinicians should consider the potential association between DM and COVID-۱۹.  Objectives: This study aimed to review COVID-۱۹ and DM comorbidity in children. Methods: ISI Web of Science, PubMed, and Google Scholar were investigated to find relevant articles regarding COVID-۱۹ and DM. Results: Data revealed ۵۰% higher fatal outcomes of COVID-۱۹ in DM children than in healthy ones. Because of the importance of DM in children, it seems mandatory to consider type ۱ diabetes and its consequences on COVID-۱۹. Conclusions: Understanding the pathophysiology of COVID-۱۹ and its interaction with DM are helpful for better management of the disease. These considerations can help clinicians make better decisions about the treatment modalities, management, and diabetic ketoacidosis treatment.

COVID-۱۹, Child, Diabetes mellitus